Medcast news and blog
PODCAST: Addressing disease burden, risk factors and health behaviours in Australian males aged 18-44
Men’s Health Week is June 10 -16 2024. Listen in to this podcast to learn about what is impacting the health and wellbeing of Australian men and how we can support males to adopt healthy behaviours.
READ ON![PODCAST: Engaging Australian males in healthy lifestyles](/media/w2vjledk/healthy-male-podcast-3-blog.webp?width=800&height=600&v=1daf4a5763c5ea0)
Chronic disease is underpinned by lifestyle and health behaviour choices across the life course. Listen in as we discuss the impact of health behaviours on Australian males and the strategies you can adopt to better support males to improve their health and wellbeing.
![Cardiovascular disease and erectile dysfunction - Clinical Opal](/media/xwsd4pmu/sexual-function-clinical-opal.webp?width=800&height=600&v=1daf4a561cd32f0)
This article explores the case of Vince, a 58-year-old social smoker with heart disease risk factors. With high blood pressure, obesity, and hyperlipidemia, his focus shifts to managing erectile dysfunction while addressing cardiovascular risks.
![PODCAST: Testosterone - a marker of male health](/media/ercdhw0w/testosterone.webp?width=800&height=600&v=1daf4a55e9dc4f0)
Join Healthy Male in this podcast as we explore testosterone as an indicator of underlying health problems and how to assess and manage these in practice.
![PODCAST: PSA testing in general practice - screening, assessment and monitoring](/media/lzglydur/screenshot-2023-11-23-at-121509-pm.webp?width=800&height=600&v=1daf4a556da28d0)
This podcast highlights the crucial role of PSA testing in diagnosing and treating prostate cancer, the most-diagnosed cancer among Australian males. Emphasising harm reduction, it discusses advancements since 2015 and supports active surveillance for low-grade cancers.
![Clinical Opal - Active surveillance](/media/1e0jo55d/prostate_opal.webp?width=800&height=600&v=1daf4a54a39bcd0)
Cameron is a 68 year old male who was diagnosed with low-risk prostate cancer six months ago.